IL23183A - 13beta-n-propyl-18,19-bis-nor-progesterone and process of preparation thereof - Google Patents
13beta-n-propyl-18,19-bis-nor-progesterone and process of preparation thereofInfo
- Publication number
- IL23183A IL23183A IL2318365A IL2318365A IL23183A IL 23183 A IL23183 A IL 23183A IL 2318365 A IL2318365 A IL 2318365A IL 2318365 A IL2318365 A IL 2318365A IL 23183 A IL23183 A IL 23183A
- Authority
- IL
- Israel
- Prior art keywords
- propyl
- bis
- acid
- des
- conducted
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 19
- 229960003387 progesterone Drugs 0.000 title claims description 10
- 239000000186 progesterone Substances 0.000 title claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- 239000003054 catalyst Substances 0.000 claims description 8
- 239000007800 oxidant agent Substances 0.000 claims description 7
- -1 pyrrolidyl Chemical group 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 6
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical group O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 150000001340 alkali metals Chemical class 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 125000005936 piperidyl group Chemical group 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 4
- 230000003301 hydrolyzing effect Effects 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 3
- IMNRJGSQCGFPHL-UHFFFAOYSA-N benzene;oxolane Chemical compound C1CCOC1.C1=CC=CC=C1 IMNRJGSQCGFPHL-UHFFFAOYSA-N 0.000 claims description 3
- 150000002081 enamines Chemical class 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 230000036571 hydration Effects 0.000 claims description 3
- 238000006703 hydration reaction Methods 0.000 claims description 3
- ARNWQMJQALNBBV-UHFFFAOYSA-N lithium carbide Chemical group [Li+].[Li+].[C-]#[C-] ARNWQMJQALNBBV-UHFFFAOYSA-N 0.000 claims description 3
- 150000003335 secondary amines Chemical class 0.000 claims description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- 239000006229 carbon black Substances 0.000 claims description 2
- 230000000887 hydrating effect Effects 0.000 claims description 2
- 238000005984 hydrogenation reaction Methods 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 1
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 claims 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims 1
- 241000575946 Ione Species 0.000 claims 1
- YTAHJIFKAKIKAV-XNMGPUDCSA-N [(1R)-3-morpholin-4-yl-1-phenylpropyl] N-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamate Chemical compound O=C1[C@H](N=C(C2=C(N1)C=CC=C2)C1=CC=CC=C1)NC(O[C@H](CCN1CCOCC1)C1=CC=CC=C1)=O YTAHJIFKAKIKAV-XNMGPUDCSA-N 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- 239000003456 ion exchange resin Substances 0.000 claims 1
- 229920003303 ion-exchange polymer Polymers 0.000 claims 1
- 150000002730 mercury Chemical class 0.000 claims 1
- 229940099990 ogen Drugs 0.000 claims 1
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 48
- 239000000203 mixture Substances 0.000 description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 239000012074 organic phase Substances 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000001195 anabolic effect Effects 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- OUNLEGKRZUPPOS-ONTSXIIYSA-N 1-[(8r,9s,10s,13s)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12-decahydro-1h-cyclopenta[a]phenanthren-17-yl]ethanone Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1C1=CC=C(C(=O)C)[C@@]1(C)CC2 OUNLEGKRZUPPOS-ONTSXIIYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DJPZSBANTAQNFN-UHFFFAOYSA-N Testosterone acetate Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(OC(=O)C)C1(C)CC2 DJPZSBANTAQNFN-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000001548 androgenic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000000962 progestomimetic effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- DJPZSBANTAQNFN-PXQJOHHUSA-N testosterone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)C)[C@@]1(C)CC2 DJPZSBANTAQNFN-PXQJOHHUSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
C O H E N Z E D E K & S P I S B A C H
REGD. PATENT ATTORNEYS
24, LEVONTIN STR., P. O. B. 1169
T E L - A V I V
P A T E N T S & D E S I G N S O R D I N A N C E 13036/65
SPECIFICATION
13β-η-ϊ¾0ΡΏι-18#19HBIS-H0R-iK0QESm01iE
ABB PROCESS OF PBEPARA!PIQH
r' 'i
WE, ROUSSBL-UCLAF, a FreiMih Body Corporate § ί
of 35» Boulevard des Iimilides, Paris 7e» France,
O HEREBY DECLARE the nature of this invention and in what manner the same is to be performe
to be particularly described and ascertained in and by the following statement :¾
ί I
which comprises the steps of:
a) reacting 5-methoxy-13£-n-propyl-A * -des-A-gonatrlene-173-ol with an oxidizing agent,
b) ethynylating the resulting 5-methoxy-13£-n- 57 Q
propyl-Δ ' -des-A-gonatriene-17-one by the action of an ethynylating agent,
c) esterifylng the resulting 5-methoxy-13£-n- 579
propyl-17a-ethynyl-A ' -des-A-gonatriene-17j5-ol by the action of an esterifylng derivative of an organic carboxyllc acid having from 2 to 7 carbon atoms, -.
d) hydrating the ethynyl function of the
resulting ester of the formula
wherein Ac represents the acyl of an organic carboxyllc acid having from 2 to 7 carbon atoms, by the action of water in the presence of a hydration catalyst,
of the ormula
wherein Ac represents the acyl of an organic carboxylic acid having from 2 to 7 carbon atoms, by the action of an alkali metal in liquid ammonia and subjecting the resulting product to an acid hydrolysis,
f) reacting the resulting 13£-n-propyl-18,19- 9
bis-nor-Δ -des-A-pregnene-20-ol-5-one with an oxidizing agent,
g) reacting the resulting 13£-n-propyl-18,19-bis-nor-A^-des-A-pregnene-5,20-dione with a secondary amine j of the formula NH wherein R and It, are members
selected from the group consisting of alkyl having from
1 to 8 carbon atoms and, when taken together with the
nitrogen, pyrrolidyl, piperidyl and morpholyl,
h) reacting the resulting enamine of the formula
consisting of alkyl having from 1 to 8 carbon atoms and, when taken together with the nitrogen, pyrrolidyl,
piperidyl and morpholyl, with l-halo-3-chloro-2-butene in an organic solvent,
i) reacting the resulting 3-chloro-13j3-n-propyl- 2 9
18,19-bis-nor-4,5-seco-A ' -pregnadiene-5,20-dione with an acid hydrolyzing agent,
j) reducing the resulting 13£-n-propyl-18,i9-bis- Q
nor-4,5-seco-A -pregnene-3,5,20-trione by the action of hydrogen in the presence of a hydrogena ion catalyst,
k) cyclizing the resulting 13£-n-propyl-18,19-bis-nor-4,5-seco-pregnane-3,5,20-trione by the action of a cyclizing agent selected from the group consisting of acidic and basic cyclizing agents, and
1) recovering-said 13j3-n-propyl-18,19-bis-nor-progesterone,
A further object of the invention is the
obtention of the novel intermediates :
a) 5-methoxy-13j3-n-propyl-A^'^'^-des-A- gonatriene-17-one
579
A * - r
together with the nitrogen, pyrrolidyl,
piperidyl and morpholyl,
h) 3-chloro-13jB-n-propyl-18,19-bis~nor- ,5- 2 9
seco-Δ ' -pregnadiene-5,20-dione,
i) 13j3-n-propyl-18,19-bis-nor- ,5-seco-A^- pregnene-3,5,20-trione
i) 13p-n-propyl-18,19-bis-nor- ,5-seco-pregnane- 3,5,20-trione
"" 3 5
k) 3-pyrrolidyl-13£«n-propyl-18,19-bis-nor-Δ ' -I pregnadiene-20-one.
These and other objects of the invention will become more apparent as the description thereof proceeds.
The compound of formula I, 13j8-n-:propyl-18,19- bis-nor-progesterone having a specific rotation /oc/p = II +149.5° ± 1 (c » QA7 in methanol) presents the stereochemical configuration of the natural steroids.
This compound- possesses interesting physiological properties. 130-n-propyl-18,19-bis-nor-progesterone is devoid of all progestomimetic activity at customary doses 1 when administered orally, on the other hand, it has a remarkable anti-androgenio effect. Thus, when administered I at the same time as a product having an androgenic and an anabolic activity such as testosterone acetate, it reduces the effects of the latter on the sexual receptors by about . !| 50 without modifying the anabolic effect.
The process of preparing the 13£-n-propyl-18,19- bis-nor-progesterone, also an object of the invention, is summarized by the flow diagram of the Table.
c represen s e acy o an organ c car oxy c ac
having from 2 to 7 carbon atoms.
R and ^ are members selected from the group consisting of alkyl having from 1 to 8 carbon atoms and, when taken together with the nitrogen, pyrrolidyl, piperidyl and morpholyl.
This process is essentially characterized in
7 9
that ~5-methoxy-13B-n-propyl-A -des-A-gonatriene-17/3-ol is subjected to the action of an oxidizing agent under the · usual conditions to oxidize the hydroxy group to a ketone.
An ethynylating agent is reacted with the resultant
7
-methoxy-138-n-propyl-A -des-A-gonatriene-17-one (II),
7 9 thus obtaining 5-methoxy-138-n-propyl-17a-ethynyl-A ' ' -des-A-gonatriene-178-ol (III). This latter compound is esterified with the aid of a functional derivative of an organic carboxylic acid, having from 2 to 7 carbon atoms to give a 5-methoxy-13 -n-propyl-17iS-acyloxy-17 t~ethynyl- 5 7 9"
Δ -des-A-gonatriene (IV). The ethynyl function of this ester is catalytically hydrated to give a 5-methoxy-13jS- 5 7
n-propyl-17j3-acyloxy-17a-acetyl-A ' ·' -des-A-gonatriene (V).
This compound V is reduced by means of an alkali metal in liquid ammonia; next an acid hydrolysis is effected, thus
q '
giving 135-n-propyl-18,19-bis-nor-A -des-A-pregnene-20-ol-5-one (VI), which is subjected to the action of an
oxidizing agent. The resultant 138-n-propyl-18,19-bis-nor-A^-des-A-pregnene-5,20-dione (VII), is reacted with a secondary amine of the formula:
in which, as well as in the following,- R and which may
e en ca or eren , are mem ers se ec e rom e group consisting of alkyl having from 1 to 8 carbon atoms, and, when taken together with the nitrogen, pyrrolidyl, plperidyl and morpholyl, which leads to the 5-enaraino-13p-n-propyl-18, 19-bis-nor-A^^10^^^11^-des-A-pregnadiene-20-one (VIII). This enamine is condensed with a l-halo-3-chloro-2-butene to give 3-chloro-138-n-propyl-18,19-bis- " 2 9
nor- ,5-seco-A * -pregnadiene-5,20-dione (IX). This last product is reacted with an acid hydrolyzing agent to obtain 135-n-propyl-18,l9-bis-nor-4 •,5-seco-A9-pregnene-3,5,20-trione (X), which is reduced by catalytic
hydrogenation to 13j3-n-propyl-18,19-bis-nor- ,5-seco-pregnane-3,5,20-trione (XI). This latter is subjected to the action of an acid or basic cyclizating agent and the desired 13S«-n-propyl-18,19-bi3-nor-progesterone, I, is obtained.
The performance of the process of invention may be characterized advantageously by the following points. a) The oxidizing agent utilized to oxidize the hydroxyl
57 '
group of 5-methoxy-13j3-n-propyl-A ' * -des-A-gonatriene- 17j3-ol into the 17 ketone, is preferably chromic acid anhydride, and the reaction is conducted in the presence of sulfuric acid In an acetonic media;
b) The ethynylating agent, which is allowed to act upon
'
the 5-niethoxy-13£-n-propyl-A * * -des-A-gonatriene-17- one (II) can be any ethynylating agent conventionally used to ethynylate a 17 ketone steroid, .however it is preferable to utilize an alkali metal acetylide in an organic solvent, such as lithium acetylide in a
benzene-tetrahydrofuran media.
- ·
g e secon ary amine which is reac ed wi h .8-n-propy - 18, 19-bis-nor-A^-.des-A-pregnene-5,20-dione (VT ), is preferably pyrrolidine and the reaction is conducted at an elevated temperature up to the reflux temperature. h) The 1-h 1 o-3-chl or0- -butene which is condensed with the 5-enamino-13£-n-propyl-18, 19-bis-nor-A^ ( 10) ' ^ ( H ) des-A-pregnadiene-20-one (VIII ) is l,3-dichloro-2- butene and the reaction is conducted in dimethylformamide in the presence of potassium iodide.
i ) The acid hydrolyzing agent which is reacted with
2 9
3-chloro-13j3-n-propyl-18, 19-bis-nor-4, 5-seco-A ' - pregnadiene-5,20-dione (IX), is a strong mineral acid such as sulfuric acid,
j ) The catalytic hydrogenat ion of 13S-n-propyl-18,19-bis- Q
nor-4,5-seco-A -pregnene-3, 5,20-trione (X), is
accomplished in a hydroxylated solvent suc as ethanol, in the presence of a small quantity of a basic reacting compound, such as a tertiary amine,' for example,
triethylamine and by utilizing a palladized carbon black hydrogenation catalyst.
k) The acidic cyclizating agent which is reacted with
13|3-n-propyl-18, 19-bis-nor-4, 5-seco-pregnane-3, 5,20- trione (XI), is preferentially hydrochloric acid, the reaction being conducted in an acetic acid media.
1 ) The basic cyclizating agent which is reacted with
13j5-n-propyl-18, 19-bis-nor- , 5-seco-pregnane-3, 5,20- trione is preferentially pyrrolidine, which leads to an intermediary compound, 3-pyrrolidyl-13£-n-propyl-18, 19- bis-nor-Δ 3 ' 5 -pre nadiene-20-one (XII) . An acid
hydrolysis of this compound, preferably by acetic acid j . gives the desired 130-n-propyl-18,19-bis-nor-progesterone;
The starting product for the process described, or 5-methoxy-13£-n-propyl-A-*' ^ ' ^-des-A-gonatriene-17j3-ol, may be prepared according to the process described in
United States Patent No. 3, 115, 507, issued December 24, 1963.
The following example illustrates the invention. It is to be understood, however, that it presents no
limiting characteristics .
EXAMPLE
ς 7 Q
Step I: 5-methoxy-13g-n-propyl-A -des-A-gonatriene- 17-one, II.
A solution of 24 gm of 5-methoxy-13p-n-propyl- des-Α-Δ 5 7 9 -gonatriene-17j3-ol in 480 cc of pure acetone was cooled to +2°C. and within a space of 5 minutes the following solution was introduced : ·
Chromic acid anhydride. . . 7.65 gm
Water .'·. . 76.5 cc
Concentrated sulfuric acid. ... 7.6 cc
Next the reaction mixture was agitated for 3 hours at +20*C , then 8.5 cc of methanol were introduced. The mixture was further agitated for another 15 minutes, then poured into 4, 750 cc of water. The aqueous mixture was extracted with methylene chloride. The extracts were washed first with an aqueous saturated solution of sodium bicarbonate, and thereafter with water until the wash waters were neutral and finally dried. The extract was then evaporated under vacuum to dryness, and the solid residue obtained was crystallized from isopropyl ether.
After vacuum filtering and drying 19.2 gm of 5-methoxy-13£-i n-propyl-Δ 5 ' 7 * 9 -des-A-gonatriene-17-one (II), were
i isolated. This product occurred, in the form of colorless
ys s, v ng a me ng po n o . an a spec c rotation a D - +67.7° (c » 0.5 in methanol).
The product was insoluble in water, and soluble in acetone, benzene and methylene chloride.
This compound is not described in the literature.
7 9
Step II: 5-methoxy»133-n-propyl-17a~ethynyl-A ' ' -des-A- gonatriene-173-»ol (III).
A solution of lithium acetylide in a benzene-tetrahydrofuran media was prepared by allowing acetylene to bubble through a mixture of 1560 cc of tetrahydrofuran and 1560 cc of a normal solution of butyl-lithium in benzene over a period of 3 hours < at.30-35°C
This solution was heated to 50°C. and, over a period of 5 minutes, 12.5 gm Of 5-methoxy-13j6-n-propyl-Δ -des-A-gonatriene-17-one (II), dissolved in 175 cc of tetrahydrofuran, were introduced. The mixture was heated to reflux for 2 hours, then cooled to 0°C , and within a period of 30 minutes, without exceeding 20°C,
3000 cc of an aqueous saturated solution of ammonium chloride were introduced therein.
The solution was decanted. The aqueous phase was separated and extracted with ether. The combined organic phases were washed with water, dried over sodium sul ate and evaporated to dryness .
A resin was thus obtained, which was dissolved in methylene chloride and subjected to chroma ography through silica gel. On elution with methylene chloride containing 2% of acetone, 12.17 gm of 5-methoxy-13j3-n- 5 7 9
propyl-17cx-ethynyl-A * -des-A-gonatriene-17£-ql (III),
- ·
were ob ained. This product was utilized as such fo e following step.
This compound is not described in the literature.
Step III: 5-methoxy-13β-n-p opy 1 — 7/5-ace oxy-17α-e hynyl- Δ^'^* ^-des-A-gonatriene (IV, Ac = CH^CO).
To a solution of 12.11 gm of 5-methoxy-13/3-n- opyl-17a-ethynyl-A 5 7
pr ' 9-des-A-gonatriene-17jS-ol (III), in 121 cc of acetic acid anhydride, 6.055 gm of p-toluene sulfonic acid monohydrate were added at a temperature of 25°C. For a period of 20 hours this mixture was agitated at a temperature of 20-25°C. Then, 600 cc of water were introduced in the reaction mixture and it was agitated for 2 hours at 20-25°C. The aqueous mixture was extracted with methylene chloride. The combined organic phases were washed successively with water, then with a saturated solution of sodium bicarbonate and finally with water until the wash waters were neutral, dried over sodium sulfate and evaporated under vacuum to dryness. In this manner a resin was obtained, which was dissolved in methylene chloride and subjected to chromatography through silica gel. On elution with methylene chloride containing 1 of acetone, 11.91 gm of 5-methoxy-13/S-n-propyl-17i3-acetoxy-17a-ethynyl-A5,7,9-des-A-gonatriene-(IV, with Ac = H^CO) were recovered. The product obtained was utilized as such for the following step.
This compound is not described in' the literature.
- - - - . (V, with Ac a CH^CO), were recovered. The product was utilized as such for the following step.
This compound is not described in the literature.
Step V: 13ff-n-propyl-18 , 19÷~bis-nor-A^-des -A-pregnene-5 , 20- dione (VII) .
625 cc of anhydrous ammonia were condensed at a temperature of -75°C , and, within the space of 15 minutes,
1.75 g» of lithium, cut into small pieces, were introduced therein. The mixture was agitated for a period of 30
minutes at -70°C , then, within a period of 10 minutes,
125 cc of anhydrous ether were added thereto. Thereafter, within a period of 10 minutes, a solution of 2.5 m of -methoxy pr toxy 5 * 7
-13£-n- opyl-17j5-ace -17ct-acetyl-A ' 9 -des-A-gonatriene (V, with Ac =» CH CO) in 125 cc of anhydrous ether was added. Finally, within a period of 10 minutes, another 125 cc of anhydrous ether were added. The reaction mixture was then subjected to a vigorous agitation, first for 2 hours at -70*C , then for 3 hours at - 0°C. Then, at - 0*C. , 75 cc of methanol were added within a period of 30 minutes . The ammonia was distilled from the reaction mixture and the temperature was allowed to rise to +20°C . Then, under agitation, first 625 of methylene chloride, then 2 0 cc of water were added. The mixture wa§ allowed to separate, the organic phase was decanted and washed
3 times with 250 cc of water.
Thereafter, 5 cc of a 2 :1 per volume mixture of methanol and concentrated hydrochloric acid were added and the mixture was heated to +70°C. to remove the ether and
- '
e me y ene c or e. e mix ure was he a + . o. 10 minutes, cooled to room temperature and an aqueous solution of sodium bicarbonate was added. The mixture was extracted with methylene chloride. The organic phase was washed with water, dried and evaporated to dryness under vacuum. In this manner, 2.34 gm of a resin were obtained, which was dissolved under atmosphere of nitrogen in 42.5 cc of methanol. 4.7 cc of concentrated hydrochlori acid were added thereto and the mixture was heated at reflux for 10 minutes. The reaction mixture was cooled to room temperature and poured into a saturated aqueous solution of sodium bicarbonate. This aqueous mixture was then extracted with methylene chloride. The organic phase was washed with water and dried.
The extract was then evaporated to dryness and a resin. as obtained which was dissolved in 43.6 cc of pure acetone. To this solution, cooled to 0°C, within a period of 3 minutes, the following solution was added:
Chromic acid anhydride........ 665 mg '
Concentrated sulfuric acid.... 0.66 cc
Water... 6.6 cc
This reaction mixture was agitated for 3hhours at 20-25°C. 7.4 cc of methanol were then Introduced into this mixture, which was agitated for a further 5 minutes. Then the mixture was poured into 400 cc of water. The aqueous mixture was extracted with methylene chloride.
The organic phase was washed, first with a saturated aqueous- solution of sodium bicarbonate, then with water and dried. The organic phase was then evaporated to dryness under atmosphere of nitrogen and 1.15_^gm of resin was obtained.
,
methylene chloride, 250 cc of a saturated aqueous solution of sodium chloride were added, and the solution was again extracted with methylene chloride. By an identical
treatment, a further 0.85 gm of resin was recovered.
The two resins were combined by dissolving them in 4 cc of isopropyl ether heated to reflux. On cooling, 440 mg of crystals were separated, which,
recrystallized from isopropanol, yielded 370 mg of
13^-n-propyl-18,19-bis-nor-A^-des-A-pregnene-5,20-dione (VII). This product had a melting point of 167°C. and a specific rotation a D « +46.6° + 0.5 (c « 0.8 in
methanol).
The product occurred in the form of colorless crystals insoluble in water, slightly soluble in hot isopropanol and soluble in methylene chloride.
This compound is not described in the literature.
isolated, having a melting point of 171°C. and a specific rotation /a/D » +213* ± 1 (e « 0.66 in benzene).
The product occurred in the form of yellow crystals, insoluble in water, methanol, and soluble in benzene.
This compound is not described in the literature.
Step VII: 3-chloro»-13.e-n-propyl'-18>19-'bis-nor-4,5~seco»
A2 Q-pregnadiene-5» 0-dione (IX).
While operating in the absence of' light and at a
minutes, then 0.21 cc of freshly distilled 1,3-dichloro-2-butene were added. The mixture was agitated for 4 hours at 0°C. under atmosphere of nitrogen. Next, 0.4 cc of water was added thereto and the temperature was raised to 90°C. within a period of 30 minutes and maintained at this temperature for 2 hours. The mixture was then cooled to room temperature, diluted with 20 cc of water and extracted with methylene chloride. The extract was washed with water, dried and evaporated to dryness. The residue was dissolved in methylene chloride and purified by passing it through "Plorisil". After evaporation, 50Q mg of product were obtained.
Claims (1)
- c ) esterifying the resulting 5-methoxy-13j3-n--propyl -17a-ethynyl -Δ 5 7 9 -des-A-gonatriene-17j8-ol by the action of an esterifying derivative of an organic carboxylic acid having from 2 to 7 carbon atoms, d) hydrating the ethynyl function of the resulting ester of the formula wherein Ac represents the acyl of an organic carboxylic acid having from 2 to 7 carbon atoms, by the action of water in the presence of a hydration catalyst, e ) reducing the resulting 17a-acetyl-gonatriene of the formula wherein Ac represents the acyl of an organic carboxylic acid having from 2 to 7 carbon atoms, by the action of an alkali metal in liquid ammonia and subjecting the resulting product to an acid hydrolysis, 73 k) cyclizing the resulting 13j3-n-propyl-18,19' 7 bis-nor- ,5-seco-pregnane-3J,5J20-trione by the action of a j 75 cyclizing agent selected from the group consisting of 76 acidic and basic cyclizing agents, and 77 1) recovering said 13]3-n-propyl-18J,19-bis-nor-78 progesterone. 5. The process of claim , step a) wherein said oxidizing agent is chromic acid anhydride and the reaction is conducted in the presence of sulfuric acid in an acetonic media. 6. The process of claim 4, step b) wherein said ethynylating agent is lithium acetylide in a benzene- tetrahydrofuran media. 7. The process of claim 4, step c) wherein said esterifying derivative of an organic carboxylic acid having from 2 to 7 carbon atoms is acetic acid anhydride in the presence of p-toluene sulfonic acid as a catalyst. 8. The process of claim 4, step d) wherein said hydration catalyst is a mercuric catalyst selected from the group consisting of the mercury salt of p-toluene sulfonamide and an ion exchange resin containing mercuric cations and the reaction is conducted. in an aqueous- alkanolic media. 9. The process of claim 4, step e) wherein said alkali metal is lithium and the reducing reaction is conducted in the presence first of diethyl ether and then of methanol and the subsequent acid hydrolysis is effected j ! by a strong mineral acid. j ■ i! I . I I 10. .The process of claim 4, step f ) wherein said oxidizing agent is chromic acid anhydride and the reaction is conducted in the presence of sulfuric acid and in an acetonic media. 11. The process of claim 4, step g) wherein said secondary amine is pyrrolidine and the reaction is conducted at elevated temperatures up to the reflux temperature. 12 . The process of claim 4, step h) wherein said l-halo-3-chloro-2-butene is lj, 3-dichloro-2-butene and the reaction is conducted in dimethylformamide in the presence of potassium iodide. 13. The process of claim 4, step i) wherein said acid hydrolyzing agent is concentrated sulfuric acid. 14. The process of claim 4, step j) wherein said hydrogenation catalyst is palladized carbon black and the ί reaction is conducted in the presence of a small amount of triethylamine in an alkanolic media. 15. The process of claim 4, step k) wherein said cyclizing agent is hydrochloric acid in acetic acid and 13jS-n-propyl-18, 19-bis-nor-progesterone is recovered. 16. The process of claim 4, step k) wherein said cyclizing agent is pyrrolidine and 3-pyrrolidyl-13jS- 3,5 n-propyl-18, 19-bis-nor-A -pregnadiene-20-one is recovered, which compound is. subjected to an acid hydrolysis to give 13jS-n-propyl-18, 19-bis-nor-progesterone. 3. 13£-n-propyl-18,19-bIs-ηοΓ-Δ^-des-A■ pregnene-20-ol-5-ofte. 24. 13£-n-propyl-18,19-bis-nor-^-des-A-pregnene-5,20-dione. 25. An enamine of the formula wherein R and are members selected from the group consisting of alkyl having from 1 to 8 carbon atoms and, when taken together with the nit ogen, pyrrolidyl, piperidyl and morpholyl. 26. 5-pyrrolidyl-13jB-n-propyl-18,19-bis-nor 5(10),9(11) Δ -des-A-pregnadiene-20-one. 3-chloro-13j3-n-propyl-18,19-bis-nor- 2,9 seco-Δ -pregnadiene-5 O-dione. 9 28. 133-n-propyl-18,19-bis-nor-4,5-seco^ -pregnene- , ,20- ione. DATED THIS 18th day of COHEN ZBDBK & SPISBACH P.O.BOX 1169, TEL AVIV Attorneys for Applicants,
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR968659A FR1492767A (en) | 1964-03-25 | 1964-03-25 | Bis nor-18, 19 13-alkylated progesterone and method of preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL23183A true IL23183A (en) | 1969-01-29 |
Family
ID=8826345
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL2318365A IL23183A (en) | 1964-03-25 | 1965-03-19 | 13beta-n-propyl-18,19-bis-nor-progesterone and process of preparation thereof |
| IL3095565A IL30955A (en) | 1964-03-25 | 1965-03-19 | 13beta-n-propyl-des-a-and 4,5-seco-pregnene compounds and process for preparing same |
| IL3095665A IL30956A (en) | 1964-03-25 | 1965-03-19 | 13beta-n-propyl-des-a-gonatrien-5-ols and process for preparing same |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL3095565A IL30955A (en) | 1964-03-25 | 1965-03-19 | 13beta-n-propyl-des-a-and 4,5-seco-pregnene compounds and process for preparing same |
| IL3095665A IL30956A (en) | 1964-03-25 | 1965-03-19 | 13beta-n-propyl-des-a-gonatrien-5-ols and process for preparing same |
Country Status (12)
| Country | Link |
|---|---|
| AT (1) | AT267080B (en) |
| BE (1) | BE660827A (en) |
| BR (1) | BR6568071D0 (en) |
| CH (1) | CH435265A (en) |
| DE (1) | DE1468903A1 (en) |
| DK (1) | DK112871B (en) |
| ES (1) | ES310879A1 (en) |
| FR (1) | FR1492767A (en) |
| GB (4) | GB1084164A (en) |
| IL (3) | IL23183A (en) |
| NL (1) | NL6503835A (en) |
| SE (1) | SE314067B (en) |
-
0
- GB GB1084166D patent/GB1084166A/en active Active
- GB GB1084167D patent/GB1084167A/en active Active
- GB GB1084165D patent/GB1084165A/en active Active
- GB GB1084164D patent/GB1084164A/en active Active
-
1964
- 1964-03-25 FR FR968659A patent/FR1492767A/en not_active Expired
-
1965
- 1965-03-09 BE BE660827D patent/BE660827A/xx unknown
- 1965-03-17 DK DK135065A patent/DK112871B/en unknown
- 1965-03-19 IL IL2318365A patent/IL23183A/en unknown
- 1965-03-19 IL IL3095565A patent/IL30955A/en unknown
- 1965-03-19 IL IL3095665A patent/IL30956A/en unknown
- 1965-03-23 DE DE19651468903 patent/DE1468903A1/en not_active Withdrawn
- 1965-03-23 ES ES0310879A patent/ES310879A1/en not_active Expired
- 1965-03-23 CH CH402365A patent/CH435265A/en unknown
- 1965-03-23 SE SE376765A patent/SE314067B/xx unknown
- 1965-03-24 BR BR16807165A patent/BR6568071D0/en unknown
- 1965-03-25 AT AT276165A patent/AT267080B/en active
- 1965-03-25 NL NL6503835A patent/NL6503835A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SE314067B (en) | 1969-09-01 |
| GB1084165A (en) | |
| GB1084164A (en) | |
| GB1084167A (en) | |
| BE660827A (en) | 1965-09-09 |
| DE1468903A1 (en) | 1969-01-16 |
| FR1492767A (en) | 1967-08-25 |
| ES310879A1 (en) | 1965-06-01 |
| NL6503835A (en) | 1965-09-27 |
| CH435265A (en) | 1967-05-15 |
| DK112871B (en) | 1969-01-27 |
| GB1084166A (en) | |
| IL30955A (en) | 1969-02-27 |
| AT267080B (en) | 1968-12-10 |
| IL30956A (en) | 1969-02-27 |
| BR6568071D0 (en) | 1973-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wall et al. | Steroidal Sapogenins. XXVIII. 2 Conversion of Steroidal Sapogenins to Δ16-20-Keto-pregnenes3 | |
| Antonucci et al. | Δ5, 7-Steroids. XII. 1, 2 Steroidal Cyclic Ketals. I. Cyclic Ketals of Δ4, 7-3-Ketosteroids | |
| Julian et al. | Sterols. IV. Δ20-Pregnenes from bisnor-steroid acids | |
| US3682983A (en) | Preparation of {66 {11 {11 -17 ethinyl steroids | |
| IL33162A (en) | Estra-(gona)-5(10)9(11)-diene derivatives | |
| US2918463A (en) | 17-carboxyalkylated 17-hydroxy-19-norandrosten-3-ones | |
| Eadon et al. | Mass spectrometry in structural and stereochemical problems. CCXI. Effect of structural variations on the electron impact-induced fragmentations of steroid hydrocarbons | |
| Dauben et al. | Synthesis of A-norcholesterol | |
| IL23183A (en) | 13beta-n-propyl-18,19-bis-nor-progesterone and process of preparation thereof | |
| Wolff et al. | The Synthesis of C-18 Functionalized Hormone Analogs. III. Synthesis of Aldosterone1a | |
| Rausser et al. | 16-Alkylated Corticoids. IV. 1 Synthesis of 16β-Methyl Analogs of Cortisone, Prednisone, and 9α-Fluoroprednisolone2 | |
| US3637770A (en) | Process for the production of 16alpha 17alpha-dihydroxy-19-nor-progesterone | |
| US3332968A (en) | Intermediates in the preparation of 17alpha-ethynyl-19-nor steroids | |
| US3483226A (en) | 16-oxa and 17 - oxa - d - homoestra - 1,3,5(10)-trien-3-ols and d-nor-seco-diols corresponding,ethers and esters thereof | |
| SATO et al. | The Chemistry of the Spiroaminoketal Side Chain of Solasodine and Tomatidine. II. 1 Chemistry of 3β, 16β-Diacetoxy-20-(2'-Δ2'-N-acetyl-5'-methyltetrahydropyridyl)-5-pregnene | |
| US2420489A (en) | Steroidal hormone intermediates and preparation of the same | |
| US3311616A (en) | 13beta-n-propyl-18, 19-bis-nor-progesterone and process of preparation | |
| US3501509A (en) | 13-alkylgona-1,3,5(10)-triene-17-one intermediates and process | |
| US3050550A (en) | Novel process for the preparation of cyclopentano-octahydronaphthalene derivatives and products obtained in this process | |
| US3313703A (en) | 19-nor-deta4, 9, 11-pregnatriene-3, 20-dione, process and intermediates | |
| US3126374A (en) | J-methyl progesterone derivatives | |
| IL32699A (en) | 6-substituted-13-polycarbonalkyl-18,19 dinorpregn-4-en-3-ones,their preparation and pharmaceutical compositions containing them | |
| US3470159A (en) | Estra-1,3,5(10),7-tetraenes and process of preparation | |
| US3083198A (en) | Novel 2-alkoxy steroids and processes for preparing the same | |
| Kundu | Radioimmunoassay of contraceptive steroids. I. Synthesis of 6-oxomestranol 6-(o-carboxymethyl) oxime |